Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.

Circulation. Cardiovascular genetics - 1 Oct 2009

Lin Hsiang-Yu, Chong Kah-Wai, Hsu Ju-Hui, Yu Hsiao-Chi, Shih Chun-Che, Huang Cheng-Hung, Lin Shing-Jong, Chen Chen-Huan, Chiang Chuan-Chi, Ho Huey-Jane, Lee Pi-Chang, Kao Chuan-Hong, Cheng Kang-Hsiang, Hsueh Chuen, Niu Dau-Ming

Abstract excerpt

BACKGROUND: Fabry disease is a treatable lysosomal storage disorder, which is often misdiagnosed or belatedly diagnosed. METHODS AND RESULTS: To determine the disease incidence in the Taiwan Chinese population, a Fabry disease newborn screening study was initiated. A total of 110 027 newborns wer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Galactosidase
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathy, Hypertrophic

Share to Fabry Disease

Share to Incidence

Share to Infant, Newborn

Share to Neonatal Screening

Share to Taiwan

Source

Identifiers

PMID: 20031620
DOI: 10.1161/CIRCGENETICS.109.862920

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20031620-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.PMID 20031620Read ↗

Deciphering the diagnostic dilemma: A comprehensive review of the Taiwanese cardiac variant in Fabry disease.Semantic proximity Read ↗

Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).Semantic proximity Read ↗

Newborn genetic screening for Fabry disease: Insights from a retrospective analysis in Nanjing, China.Semantic proximity Read ↗

Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4 + 919G > A).Semantic proximity Read ↗

Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A).Semantic proximity Read ↗

High incidence of later-onset fabry disease revealed by newborn screening.Semantic proximity Read ↗

Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.Semantic proximity Read ↗

Clinical and genetic spectrum in Chinese families with Fabry disease: a single-centre case series.Semantic proximity Read ↗

Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.Semantic proximity Read ↗

Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A).Semantic proximity Read ↗

Successful experience with high-risk and family screening for Fabry disease in Ninghai County, Zhejiang Province, Eastern China: genotype‒phenotype analysis of the GLA IVS4 + 919G > A variant.Semantic proximity Read ↗

Fabry disease: Review and experience during newborn screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.